Bones, Fractures, Antiretroviral Therapy and HIV
- 19 February 2014
- journal article
- research article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 16 (2) , 1-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone HealthPLOS ONE, 2014
- Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in lifeAIDS, 2014
- Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy InitiationClinical Infectious Diseases, 2013
- HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatinAging Cell, 2013
- Hepatitis C Co-infection and Severity of Liver Disease as Risk Factors for Osteoporotic Fractures Among HIV-Infected PatientsJournal of Bone and Mineral Research, 2013
- Physiologic Frailty and Fragility Fracture in HIV-Infected Male VeteransClinical Infectious Diseases, 2013
- Fractures after antiretroviral initiationAIDS, 2012
- Risk of hip fracture associated with hepatitis c virus infection and hepatitis C/human immunodeficiency virus coinfectionHepatology, 2012
- Bone Turnover, Osteoprotegerin/Rankl and Inflammation with Antiretroviral Initiation: Tenofovir versus Non-Tenofovir RegimensAntiviral Therapy, 2011
- Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research DirectionsClinical Infectious Diseases, 2008